These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 20722563

  • 1. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD.
    Onuigbo MA.
    Ren Fail; 2010; 32(8):954-8. PubMed ID: 20722563
    [Abstract] [Full Text] [Related]

  • 2. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 3. Renal failure and concurrent RAAS blockade in older CKD patients with renal artery stenosis: an extended Mayo Clinic prospective 63-month experience.
    Onuigbo MA, Onuigbo NT.
    Ren Fail; 2008 Jul; 30(4):363-71. PubMed ID: 18569908
    [Abstract] [Full Text] [Related]

  • 4. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA.
    Adv Perit Dial; 2009 Jul; 25():85-8. PubMed ID: 19886324
    [Abstract] [Full Text] [Related]

  • 5. Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study.
    Onuigbo MA, Onuigbo NT.
    Ren Fail; 2008 Jul; 30(1):67-72. PubMed ID: 18197546
    [Abstract] [Full Text] [Related]

  • 6. Evidence of the syndrome of rapid onset end-stage renal disease (SORO-ESRD) in the acute kidney injury (AKI) literature--preventable causes of AKI and SORO-ESRD--a call for re-engineering of nephrology practice paradigms.
    Onuigbo MA.
    Ren Fail; 2013 Jul; 35(6):796-800. PubMed ID: 23725089
    [Abstract] [Full Text] [Related]

  • 7. Syndrome of rapid onset ESRD accounted for high hemodialysis catheter use--results of a 13-year Mayo Clinic incident hemodialysis study.
    Onuigbo M, Agbasi N.
    Ren Fail; 2015 Jul; 37(9):1486-91. PubMed ID: 26375630
    [Abstract] [Full Text] [Related]

  • 8. Chronic kidney disease progression to end stage renal disease: a single center experience of the role of the underlying kidney disease.
    Ekart R, Ferjuc A, Furman B, Gerjevič Š, Bevc S, Hojs R.
    Ther Apher Dial; 2013 Aug; 17(4):363-7. PubMed ID: 23931872
    [Abstract] [Full Text] [Related]

  • 9. Renoprevention: A new concept for reengineering nephrology care--an economic impact and patient outcome analysis of two hypothetical patient management paradigms in the CCU.
    Onuigbo MA.
    Ren Fail; 2013 Aug; 35(1):23-8. PubMed ID: 23151177
    [Abstract] [Full Text] [Related]

  • 10. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF, McCarthy M, Howse ML, Williams PS.
    Ren Fail; 2007 Aug; 29(6):653-9. PubMed ID: 17763158
    [Abstract] [Full Text] [Related]

  • 11. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M, Mann W, Derose S, Selevan D, Pascual N, Diesto J, Crooks P.
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [Abstract] [Full Text] [Related]

  • 12. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
    Imai E, Matsuo S, Makino H, Watanabe T, Akizawa T, Nitta K, Iimuro S, Ohashi Y, Hishida A, CKD-JAC Study Group.
    Hypertens Res; 2008 Jun; 31(6):1101-7. PubMed ID: 18716357
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan.
    Chiu YL, Chien KL, Lin SL, Chen YM, Tsai TJ, Wu KD.
    Nephron Clin Pract; 2008 Jun; 109(3):c109-18. PubMed ID: 18663322
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A, Grandits GA, Grimm RH, Svendsen KH, Collins AJ, Prineas RJ, Neaton JD.
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [Abstract] [Full Text] [Related]

  • 17. Late onset azotemia from RAAS blockade in CKD patients with normal renal arteries and no precipitating risk factors.
    Onuigbo MA, Onuigbo NT.
    Ren Fail; 2008 May; 30(1):73-80. PubMed ID: 18197547
    [Abstract] [Full Text] [Related]

  • 18. Incidence and outcomes of acute kidney injury in a referred chronic kidney disease cohort.
    Lafrance JP, Djurdjev O, Levin A.
    Nephrol Dial Transplant; 2010 Jul; 25(7):2203-9. PubMed ID: 20124548
    [Abstract] [Full Text] [Related]

  • 19. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H.
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [Abstract] [Full Text] [Related]

  • 20. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.